Emcure Pharma IPO

Emcure Pharmaceuticals, based in India, is involved in the development, manufacturing, and global marketing of pharmaceutical products spanning various therapeutic areas. The company has a product portfolio consisting of orals, injectables, and biotherapeutics. Emcure's products reach over 70 countries worldwide. The company operates 13 manufacturing facilities throughout India, equipped to produce pharmaceutical and biopharmaceutical products. These facilities handle dosage forms, including oral solids, oral liquids, and injectables—both liposomal and lyophilised. They manufacture biotherapeutics and complex active pharmaceutical ingredients (APIs), such as chiral molecules, iron molecules, and cytotoxic products.;